Centers for Structural Biology of HIV and Other Infectious Diseases (U54 Clinical Trial Not Allowed)
National Institutes of Health
Want a reminder before this closes?
We'll email you 3 days before the deadline. One email, then we stop.
Free. Verify your email, then we send one reminder only.
- Posted
- Dec 23, 2025
- Amount
- $3,500,000
- Closes
- May 28, 2027 (in 238 days)
Similar opportunities open now
- Silvio O. Conte Digestive Diseases Research Core Centers (P30-Clinical Trial Optional)Same funderOpenNational Institutes of HealthCloses Feb 2027Up to $750K
- Silvio O. Conte Centers for Basic Neuroscience or Translational Mental Health Research (P50 Clinical Trial Optional)Same funderOpenNational Institutes of HealthCloses May 2028
Classification and identifiers
- Solicitation number
- RFA-AI-28-031
- Assistance listing (CFDA)
- 93.310
Amount
$3,500,000
Who can apply
Small businesses can apply here. Check the eligibility details below to see if your organization fits.
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).
About this opportunity
The National Institute of Allergy and Infectious Diseases (NIAID) seeks to advance its mission by supporting the Centers for Structural Biology of HIV and other Infectious Diseases. This solicitation will support multidisciplinary groups of scientists to determine the 3-dimensional structures of molecules and molecular complexes involved in priority infectious diseases. The effort focuses on exploring biomolecular complexes that can be targeted to make new medicines and tests to prevent or treat infections and improve human health. The centers will drive cutting-edge research and development of structural biology technologies, including high-resolution 3D structural analyses, computational molecular dynamics, functional and mechanistic characterization at the molecular and cellular level, ...